生物科技和藥品類股
7.60k 個跟隨者 • 31 個股票代號 追蹤清單由 Yahoo Finance 提供
跟隨此清單即可探索和追蹤大型藥品與生物科技公司。
策劃人： Yahoo Finance
跟隨此清單即可探索和追蹤大型藥品與生物科技公司。這些公司研發醫治各種疾病與醫療情況的特製藥品和療法。雖然成功研發藥品的過程充滿風險，但成功研發的公司通常會在一段時間後帶來可觀的盈利增長，特別是取得專利時。
此清單包括三個月內每日平均交易量超過 200,000 股，而且股價為 $5 美元或以上的股票。此清單每天產生一次，並以市值排序；盈利以最新收市價計算得出，而且只列出符合條件的前 30 名股票。
此清單與已停止提供的「對抗癌症」觀察名單類似。
背景
Yahoo 財經運用先進的演算法觀察和偵測全球金融市場的趨勢。我們會以觀察名單的形式向你提供深入分析。
你可以透過 Yahoo 財經篩選器尋找其他有用的投資意見。
這些股票如何加權？此觀察名單的股票比重相等。
表現
| 追蹤清單 | 今日股價變化 | 1 個月回報 | 1 年回報 | 總回報 |
|---|---|---|---|---|
| 生物科技和藥品類股 | +0.30% | - | - | - |
| ^GSPC | -0.76% | +3.23% | +32.96% | +6152.97% |
31 個股票代號
| 代號 | 公司名稱 | 收市價 | 變化 | % 變化 | 市場時間 | 成交量 | 平均成交量 (3 個月) | 市值 |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 913.32 | -16.19 | -1.74% | 下午4:00 [EDT] | 2.27M | 3.16M | 822.38B |
| NVO | Novo Nordisk A/S | 117.81 | -1.97 | -1.64% | 下午4:00 [EDT] | 3.60M | 4.10M | 525.62B |
| JNJ | Johnson & Johnson | 164.1 | +2.50 | +1.55% | 下午4:00 [EDT] | 10.22M | 6.54M | 395.03B |
| ABBV | AbbVie Inc. | 191.86 | -2.24 | -1.15% | 下午4:00 [EDT] | 6.03M | 4.72M | 338.89B |
| MRK | Merck & Co., Inc. | 111.53 | +1.84 | +1.68% | 下午4:00 [EDT] | 7.08M | 9.54M | 282.71B |
| RHHBY | Roche Holding AG | 39.3 | +0.13 | +0.33% | 下午3:58 [EDT] | 53.44k | 1.62M | 254.23B |
| AZN | AstraZeneca PLC | 77.85 | -0.25 | -0.32% | 下午4:00 [EDT] | 2.56M | 4.55M | 241.38B |
| NVS | Novartis AG | 116.22 | -0.08 | -0.07% | 下午4:00 [EDT] | 773.56k | 1.13M | 236.41B |
| AMGN | Amgen Inc. | 325.09 | +0.47 | +0.14% | 下午4:00 [EDT] | 1.81M | 1.95M | 174.68B |
| PFE | Pfizer Inc. | 29.44 | +0.36 | +1.24% | 下午4:00 [EDT] | 21.73M | 31.84M | 166.83B |
| SNY | Sanofi | 54.57 | -0.35 | -0.64% | 下午4:00 [EDT] | 1.94M | 1.80M | 136.82B |
| VRTX | 福泰製藥 | 484.3 | -0.52 | -0.11% | 下午4:00 [EDT] | 1.25M | 1.10M | 125.00B |
| REGN | Regeneron Pharmaceuticals, Inc. | 1016.53 | +2.28 | +0.22% | 下午4:00 [EDT] | 512.42k | 537.83k | 112.06B |
| BMY | Bristol-Myers Squibb Company | 52.76 | +0.09 | +0.17% | 下午4:00 [EDT] | 10.09M | 13.15M | 106.97B |
| GILD | Gilead Sciences, Inc. | 85.82 | +0.77 | +0.91% | 下午4:00 [EDT] | 5.11M | 6.38M | 106.85B |
| ZTS | Zoetis Inc. | 192.39 | -0.26 | -0.13% | 下午4:00 [EDT] | 996.12k | 1.83M | 87.16B |
| GSK | GSK plc | 38.96 | -0.17 | -0.43% | 下午4:00 [EDT] | 4.29M | 4.04M | 79.46B |
| HLN | Haleon plc | 10.02 | -0.08 | -0.79% | 下午4:00 [EDT] | 13.57M | 5.06M | 45.31B |
| TAK | Takeda Pharmaceutical Company Limited | 14.05 | -0.29 | -2.02% | 下午4:00 [EDT] | 2.67M | 2.24M | 44.54B |
| ALNY | Alnylam Pharmaceuticals, Inc. | 287.36 | +4.04 | +1.43% | 下午4:00 [EDT] | 786.87k | 820.88k | 36.89B |
| ARGX | argenx SE | 544.71 | +1.15 | +0.21% | 下午4:00 [EDT] | 160.75k | 319.23k | 32.57B |
| BAYRY | Bayer Aktiengesellschaft | 7.24 | +0.10 | +1.40% | 下午3:55 [EDT] | 38.51k | 825.36k | 28.45B |
| BNTX | BioNTech SE | 117.53 | -2.61 | -2.17% | 下午4:00 [EDT] | 568.40k | 958.25k | 27.94B |
| BIIB | Biogen Inc. | 191.55 | -0.01 | -0.01% | 下午4:00 [EDT] | 1.43M | 1.09M | 27.90B |
| BGNE | 百濟神州有限公司 | 222.6 | -4.45 | -1.96% | 下午4:00 [EDT] | 269.34k | 316.94k | 24.93B |
| MRNA | Moderna, Inc. | 57.31 | -0.42 | -0.73% | 下午4:00 [EDT] | 4.08M | 4.78M | 22.03B |
| TEVA | Teva Pharmaceutical Industries Limited | 18.15 | +0.91 | +5.28% | 下午4:00 [EDT] | 7.28M | 7.84M | 20.56B |
| RPRX | Royalty Pharma plc | 27.84 | -0.03 | -0.11% | 下午4:00 [EDT] | 1.76M | 2.45M | 16.52B |
| SMMT | Summit Therapeutics Inc. | 21.84 | +1.59 | +7.85% | 下午4:00 [EDT] | 3.09M | 4.99M | 16.05B |
| UTHR | United Therapeutics Corporation | 359.57 | +2.47 | +0.69% | 下午4:00 [EDT] | 329.39k | 420.50k | 16.00B |
Pharmaceutical TechnologyBayer applies for EU approval of menopause drug elinzanetant
Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief pill.
Investor's Business DailyJ&J Stock Leapfrogs 50-Day Line After Health Care Titan Raises Sales Outlook
Johnson & Johnson stock rose Tuesday after the company beat Wall Street's third-quarter expectations, but cut its full-year profit forecast.
- Yahoo Finance Video
UnitedHealth, Walgreens, J&J: Health earnings in focus
Johnson & Johnson (JNJ), UnitedHealth Group (UNH), and Walgreens Boots Alliance (WBA) all reported earnings on Tuesday. To break all these earnings results down, Yahoo Finance senior health reporter Anjalee Khemlani joins Julie Hyman and Josh Lipton on Market Domination. Khemlani notes UnitedHealth's disappointing outlook as the health insurer contends with Medicare Advantage's latest coverage terms; Walgreens topped its fiscal fourth quarter estimates while planning to close 1,200 stores over the next three years; lastly, pharmaceutical giant J&J beat its earnings and revenue estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.
